首页> 外文期刊>Tumour biology : >Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases
【24h】

Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases

机译:miR-452-5p表达在肺腺癌中的临床价值:基于癌症基因组图谱和基因表达综合数据库的回顾性定量实时聚合酶链反应研究与验证

获取原文
           

摘要

The role and mechanism of miR-452-5p in lung adenocarcinoma remain unclear. In this study, we performed a systematic study to investigate the clinical value of miR-452-5p expression in lung adenocarcinoma. The expression of miR-452-5p in 101 lung adenocarcinoma patients was detected by quantitative real-time polymerase chain reaction. The Cancer Genome Atlas and Gene Expression Omnibus databases were joined to verify the expression level of miR-452-5p in lung adenocarcinoma. Via several online prediction databases and bioinformatics software, pathway and network analyses of miR-452-5p target genes were performed to explore its prospective molecular mechanism. The expression of miR-452-5p in lung adenocarcinoma in house was significantly lower than that in adjacent tissues (p
机译:miR-452-5p在肺腺癌中的作用和机制尚不清楚。在这项研究中,我们进行了系统的研究,以调查miR-452-5p表达在肺腺癌中的临床价值。通过定量实时聚合酶链反应检测miR-452-5p在101例肺腺癌患者中的表达。加入癌症基因组图谱和基因表达综合数据库以验证miR-452-5p在肺腺癌中的表达水平。通过几个在线预测数据库和生物信息学软件,对miR-452-5p目标基因进行了途径和网络分析,以探索其预期分子机制。室内肺腺癌中miR-452-5p的表达明显低于邻近组织中的表达(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号